Search
for
Sort by
Research 61–90 of 572
- Current Pharmacological Treatment for Male LUTS due to BPH: Dutasteride or Finasteride?
- 5α-Reductase: History and Clinical Importance
- Frontal fibrosing alopecia treatment options
- Efficacy and safety of 5 alpha-reductase inhibitor monotherapy in patients with benign prostatic hyperplasia: A meta-analysis
- The risk of dementia with the use of 5 alpha reductase inhibitors
- TSPO activation modulates the effects of high pressure in a rat ex vivo glaucoma model
- 5-Alpha-Reductase Inhibitors and Combination Therapy
- Steroid 5α-reductase 2 deficiency leads to reduced dominance-related and impulse-control behaviors
- Trends in the Development of New Drugs for Treatment of Benign Prostatic Hyperplasia
- Frontal fibrosing alopecia: efficacy of treatment modalities
- Inhibitors of 5α-reductase-related side effects in patients seeking medical care for sexual dysfunction.
- Predominant expression of 5 alpha-reductase type 1 in pubic skin from normal subjects and hirsute patients.
- Metabolic dysfunction in female mice with disruption of 5α-reductase 1
- Changes in serum free testosterone, sleep patterns, and 5‐alpha‐reductase type I activity influence changes in sebum excretion in female subjects
- Algorithmic approach to the treatment of frontal fibrosing alopecia: A systematic review
- Common urologic diseases in older men and their treatment: how they impact fertility
- Penile vascular abnormalities in young men with persistent side effects after finasteride use for the treatment of androgenic alopecia
- Efficacy and Tolerability of 6-Month Treatment with Tamsulosin Plus the Hexanic Extract of Serenoa repens versus Tamsulosin Plus 5-Alpha-Reductase Inhibitors for Moderate-to-Severe LUTS-BPH Patients: Results of a Paired Matched Clinical Study
- Risk of rhabdomyolysis from 5-α reductase inhibitors
- 5α-Reductase inhibitors increase acute coronary syndrome risk in patients with benign prostate hyperplasia
- Homology Modeling of 5-alpha-Reductase 2 Using Available Experimental Data
- 5-Alpha-Reductase Inhibitors Reduce Remission Time of COVID-19: Results From a Randomized Double Blind Placebo Controlled Interventional Trial in 130 SARS-CoV-2 Positive Men
- The feasibility of quantitative analysis of androgen metabolism by use of single dermal papillae from human hair follicles
- Dihydroartemisinin attenuates benign prostatic hyperplasia in rats by inhibiting prostatic epithelial cell proliferation
- <i>In vivo</i> and <i>in silico</i> evaluation of the ameliorative effect of hesperidin on finasteride-induced testicular oxidative stress in Wistar rats
- 5-alpha Reductase inhibitors and risk of male breast cancer: a systematic review and meta-analysis
- Reply to Effectiveness of dutasteride in a large series of patients with frontal fibrosing alopecia in real clinical practice
- Impact of anti-androgen therapies on COVID-19 susceptibility: a case-control study in male population from two COVID-19 regional centers of Lombardy (Italy)
- The inflammatory component of androgenetic alopecia
- Development of a Liquid Chromatography/Mass Spectrometry-Based Inhibition Assay for the Screening of Steroid 5-α Reductase in Human and Fish Cell Lines